ras inhibitor

Greg Verdine: The Scientist Who Turned an “Undruggable” Cancer Target Into a New Treatment

Greg Verdine's groundbreaking work on RAS inhibitors has led to the FDA approval of Rasonque, a new treatment for pancreatic cancer. His persistent efforts highlight the importance of long-term scientific exploration in overcoming previously deemed 'undruggable' targets in cancer treatment.